Cox, George N.
Lee, Ji I.
Rosendahl, Mary S.
Chlipala, Elizabeth A.
Doherty, Daniel H.
Funding for this research was provided by:
National Cancer Institute (R44CA084850)
Article History
First Online: 14 March 2020
Compliance with Ethical Standards
:
: GNC, DHD, MSR, and JIL are employees or former employees of Bolder BioTechnology. GNC and DHD have a financial interest in Bolder BioTechnology. GNC, DHD, and MSR are inventors on patents and patent applications owned by Bolder BioTechnology related to GM-CSF and other proteins and methods. EAC has a financial interest in Premier Laboratory, which was paid by Bolder BioTechnology to perform the animal studies described in the manuscript, as well as other animal studies.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of Premier Laboratory and the University of Colorado, Boulder, where the studies were conducted.